Phenotypic Corrections of Ex Vivo Erythrocytes Derived from Chronic Hemolytic Anemia Patients Due to Krϋppel-like Factor 1 (KLF-1) Mutations By AG-348: A Novel Synthetic Pyruvate Kinase Activator
Thidarat Suksangpleng(Siriraj Hospital), Vip Viprakasit(Siriraj Hospital), Kalaya Tachavanich, Suchada Riolueang(Siriraj Hospital), Supachai Ekwattanakit(Siriraj Hospital)
Cited by 0
Related Papers
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Clinical Classification, Screening and Diagnosis for Thalassemia
|Hematology/Oncology Clinics of North America|2018|262
Αlpha-thalassemia: A practical overview
|Blood Reviews|2024|82
Paper-based microchip electrophoresis for point-of-care hemoglobin testing
|The Analyst|2020|71